Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers
On
The following is a summary of the principal provisions of the 2021 Plan. The
following summary does not purport to be complete and is qualified in its
entirety by reference to the full text of the 2021 Plan, which was attached as
Appendix A to the Company's Definitive Proxy Statement on Schedule 14A filed on
The 2021 Plan authorizes the issuance of an additional 1,500,000 shares of the Company's Common Stock. In addition to these newly authorized shares, any shares previously reserved and available for issuance, but not issued or subject to outstanding awards, under the 2017 Plan as of the effective date of the 2021 Plan will become available for issuance under the 2021 Plan, as will any shares that are subject to outstanding awards under the 2017 Plan as of the effective date of the 2021 Plan to the extent such shares are not issued and cease to be subject to such awards following the effective date of the 2021 Plan, up to an aggregate maximum of 1,349,569 shares.
The Board or the Committee is authorized to administer the 2021 Plan. The Board or the Committee may delegate concurrent administration of the 2021 Plan to other committees consisting of one or more members of the Board or to one or more officers in accordance with the 2021 Plan's terms and any conditions established by the Board or the Committee. The plan administrator is authorized to select the individuals to be granted awards and, subject to the terms of the 2021 Plan, to determine the types of awards to be granted, the number of shares subject to awards and the other terms, conditions and provisions of such awards.
Awards may be granted under the 2021 Plan to the Company's employees, officers, directors, consultants, agents, advisors and independent contractors and those of the Company's affiliates. Under the 2021 Plan, the Committee may grant stock awards, restricted stock and stock units, performance awards, stock options, stock appreciation rights and other stock or cash-based awards.
Item 5.05 Amendments to the Registrant's Code of Ethics, or Waiver of a Provision
of the Code of Ethics
On
The new Code, as amended, supersedes the Company's existing Code of Business Conduct and Ethics previously adopted by the Board. The adoption of the new Code did not relate to or result in any waiver, whether explicit or implicit, of any provision of the existing code. The foregoing description of the new Code does not purport to be complete and is qualified in its entirety by reference to the full text of the new Code, as amended, a copy of which is attached hereto as Exhibit 14.1 and incorporated herein by reference.
The new Code, as amended, is available under the "Investors" section of the Company's website, located at https://investors.gbrx.com/corporate-governance. The contents of the Company's website are not incorporated by reference in this report or made a part hereof for any purpose.
Item 5.07 Submission of Matters to a Vote of Security Holders
At the Annual Meeting of Shareholders of the Company held virtually on
--------------------------------------------------------------------------------
Proposal 1: Election of Directors
A vote was taken at the Annual Meeting for the election of three directors of the Company to hold office until the Annual Meeting of Shareholders to be held in 2024, or until their successors are elected and qualified. The aggregate numbers of shares of Common Stock voted in person or by proxy for each nominee were as follows: Votes for Votes Broker Non- Nominee Election Withheld Votes William A. Furman 25,161,127 709,887 3,717,835 Charles J. Swindells 25,331,239 539,775 3,717,835 Kelly M. Williams 25,203,860 667,154 3,717,835
Proposal 2: Advisory Approval of Executive Compensation
A vote was taken at the Annual Meeting on the proposal to approve as a non-binding advisory resolution the 2020 compensation of the Company's named executive officers. The aggregate number of shares of Common Stock that were voted in person or by proxy for or against the resolution, that abstained from voting, or that were broker non-votes were as follows:
Votes against Broker Non- Votes for Approval Approval Votes Abstained Votes 24,822,296 916,259 132,459 3,717,835
Proposal 3: Approval of 2021 Stock Incentive Plan
A vote was taken at the Annual Meeting on the proposal to approve the 2021 Plan. The aggregate number of shares of Common Stock that were voted in person or by proxy for or against the resolution, that abstained from voting, or that were broker non-votes were as follows:
Votes against Broker Non- Votes for Approval Approval Votes Abstained Votes 24,413,393 1,361,371 96,250 3,717,835
Proposal 4: Ratification of Appointment of Independent Auditors
A vote was taken at the Annual Meeting on the proposal to ratify the appointment
of
Votes against Votes for Approval Approval Votes Abstained 28,761,119 771,950 55,780
Proposal 5: Shareholder Proposal Entitled "Independent Board Chair"
A vote was taken at the Annual Meeting on a shareholder proposal entitled 'Independent Board Chair'. The aggregate number of shares of Common Stock that were voted in person or by proxy for or against the proposal, that abstained from voting, or that were broker non-votes were as follows:
Votes against Broker Non- Votes for Approval Approval Votes Abstained Votes 6,501,904 19,276,791 92,319 3,717,835
--------------------------------------------------------------------------------
Item 9.01 Financial Statements and Exhibits
(d) Exhibits Exhibit No. Description 14.1 Code of Business Conduct and Ethics. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
--------------------------------------------------------------------------------
© Edgar Online, source